Chembio Diagnostics Total Liabilities

Chembio Diagnostics (CEMI) currently reports a total liabilities of $45M as of December 2022. That compares with $39M in the prior-year period — up 14.9% year over year. Use the charts on this page to explore Chembio Diagnostics's total liabilities history and peer comparisons.

Chembio Diagnostics's total liabilities increased from $39M to $45M — a 14.9% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chembio Diagnostics reported $45M in total liabilities as of December 2022. That compares with $39M in the prior-year period — up 14.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $45M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Chembio Diagnostics, and consider following CEMI for alerts when major investors trade the stock.

Chembio Diagnostics is classified in the Healthcare sector. On total liabilities, it currently shows $45M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CEMI with unrelated industries.